1984 Wellsville High School graduate and SUNY Geneseo alumni is the son of Tom & Roseanna O’Grady of Wellsville
| We are pleased to announce that Mr. Brendan O’Grady will be joining us as Chief Executive Officer – Global Formulations Business with effect from 10th June 2022. Brendan will be based in Watford, United Kingdom and will report to Mr. Glenn Saldanha, Chairman & Managing Director. He will be a member of the Core Operating Group (COG).In this role, Brendan will lead the Commercial Business Units for GPL and provide strategic leadership for bringing greater focus and alignment across all our regions and therapeutic areas, to better serve the needs of patients globally. He will be responsible for sustaining and driving our high growth DNA as we continue to build the growth journey for our organization across various business segments. Brendan comes with over three decades of rich experience in the Pharmaceutical industry, spread across both Generics and Specialty segments where he has successfully led and transformed businesses for growth across multiple geographies across the world. In his last engagement, Brendan was Chief Growth & Commercial Officer for Amwell, Inc. providing strategic leadership to Amwell’s global business operations. Prior to that, he was associated with Teva Pharmaceuticals, Inc. as the President & CEO, Teva USA and EVP, North America Commercial. Brendan spent over two decades at Teva during which he was instrumental in stabilizing and growing the North American business, revitalizing the Global Specialty strategy, and making significant contributions to market access strategies, brand acquisitions, and integrations. He also had significant and successful stints with Sanofi Pharmaceuticals and SC Johnson (Wax) & Son at the beginning of his career. Brendan has a Master’s degree in Business Administration from Baker University, Kansas. He also holds a Bachelor of Science degree in Management Science & Marketing from State University of New York. |
